Improper Medicare payments down $20.7B since 2014, CMS data show
Fierce Healthcare
NOVEMBER 16, 2021
since 2014, CMS data show. Improper Medicare payments down $20.7B Tue, 11/16/2021 - 07:15.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Fierce Healthcare
NOVEMBER 16, 2021
since 2014, CMS data show. Improper Medicare payments down $20.7B Tue, 11/16/2021 - 07:15.
Fierce Healthcare
AUGUST 11, 2023
Access to care for Medicaid fee-for-service beneficiaries with substance use disorder has improved from 2014 until 2021, but much more can be done to improve it further, researchers say. There have been substantial improvements in coverage for substance use disorder and opioid use disorder since 2014, according to a study in JAMA Network.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The FDA Law Blog
APRIL 8, 2025
Indeed, since 2014, DPD facilitatedthe publication of 42 quarterly batches and dozens of stand-alone PSGs, plus three one-off batches of PSGs updated to align with recommendations in general guidance documents ( g. , Publishing virtually every GDUFA guidance and MAPP since 2014 to fulfill FDAs GDUFA commitments.
PharmaVoice
JULY 18, 2023
A former WHO epidemiologist is applying lessons learned during the Ebola epidemic to her work leading a company at the forefront of women’s health: the reproductive microbiome.
Pharmacy Times
JANUARY 15, 2024
The approval was based on the results of a phase 3 trial that found an improvement in progression-free survival among individuals treated with pembrolizumab.
IDStewardship
JANUARY 5, 2025
Steven Smoke, Pharm.D., BCIDP, BCPT Five Things To Know: How To Use Artificial Intelligence To Be A Better Clinical Pharmacist Katarzyna Wojcik, PMP, PhD,Andrea Prinzi, PhD, MPH, CPH, SM(ASCP),Amanda Suchanek, Ph.D., Jessica Blavignac Microbiology Laboratory Strategies to Advance Antimicrobial Stewardship Timothy Gauthier, Pharm.D.,
Pharmacy Times
JANUARY 16, 2024
Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients.
IDStewardship
DECEMBER 1, 2022
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update. Infect Contr Hosp Epidemiol 2014; 35(8): 915–36. Clin Infect Dis 2016; 63 (5):e61–e111. . Klompas, M., Branson, R., Eichenwald, E. Tamma, Samuel L. Aitken, Robert A. Bonomo, et al.
Pharmacy Times
MAY 20, 2024
In 2014, the cobas human papillomavirus test was approved by the FDA for first-line, primary screening in women aged 25 years and older.
Fierce Healthcare
MARCH 12, 2025
A recent analysis, which looked at ophthalmology practice acquisitions between 2014 and 2021, outlines movement among the clinical workforce and changes in its characteristics that stem from private equity's increasing role in care.
Pharmacy Times
NOVEMBER 11, 2022
Updated prescribing guidelines issued in 2014 and 2016 may explain lower use of opioids by 11.7% among patients with chronic, nonsurgical pain.
Pharmacy Times
DECEMBER 15, 2022
While the use of direct-acting antiviral treatment for hepatitis C virus increased from 2014 to 2018, treatment rates have declined since 2019 and remain suboptimal.
STAT
AUGUST 1, 2024
authored the Sunscreen Innovation Act , which became law in 2014, Americans are still waiting for newer, more effective sunscreen products due to the Food and Drug Administration’s chronic inaction. A decade after Sen. Jack Reed (D-R.I.)
Fierce Pharma
FEBRUARY 8, 2024
billion in 2023 revenues, AstraZeneca has met the $45 billion-by-2023 goal CEO Pascal Soriot established in 2014 when he was fending off a takeover bid from Pfizer. AstraZeneca has met the $45 billion-by-2023 revenue goal that CEO Pascal Soriot established in 2014.
Pharmaceutical Technology
SEPTEMBER 27, 2023
The idiopathic pulmonary fibrosis (IPF) market is underserved with just two licensed pharmaceutical treatments approved by the FDA in 2014.
Pharmaceutical Commerce
JANUARY 15, 2024
FDA approves Keytruda (pembrolizumab) combined with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer, which is the 39th overall approved indication for the drug in the United States.
STAT
SEPTEMBER 18, 2023
Universities have also expanded their course offerings, with the number of new students enrolled in accredited midwifery programs growing from 1,006 students in 2014 to 1,214 in 2018 , according to the latest data available. more than doubled from 1991 and 2012 and has continued to grow steadily in the years since. Read the rest…
STAT
NOVEMBER 14, 2023
Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period. ” A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Continue to STAT+ to read the full story…
STAT
MAY 20, 2024
After his spinal cord injury in 2014, Sherown Campbell worked hard to regain as much bodily function as he could. Once a dedicated athlete, Campbell had to learn the new limits of his body. One of them, jarringly, was his body’s inability to sweat.
STAT
DECEMBER 8, 2023
Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics were all started in the 2013-2014 time frame with the same goal of turning the nascent CRISPR gene-editing technology into medicines.
Outsourcing Pharma
JUNE 7, 2021
The pharmacy company's Wegovy (semaglutide) is the first therapy designated for chronic weight management that the agency has granted approval since 2014.
STAT
OCTOBER 25, 2023
The researchers examined Medicare beneficiaries who were diagnosed with cancer and received treatment from 2014 through 2019. Overall, the proportion of patients who were prescribed so-called low-value drugs was higher when their oncologist accepted industry payments, according to the study, published in the BMJ.
STAT
OCTOBER 24, 2023
Since the Apple Watch was unveiled in 2014, it has been trumpeted not only as a high tech fashion accessory, but also as a way for people to track their own health and fitness. It has evolved as a popular cardio tool for such uses as heart rate monitoring, recording your ECG, and measuring the oxygen saturation of your blood.
Fierce Pharma
JANUARY 16, 2024
It is the second indication for HyQvia, which was first endorsed in 2014. The FDA has approved Takeda's HyQvia as a maintenance therapy for CIDP.
STAT
APRIL 19, 2024
hospitals and then tracked usage of seven antibiotics that were approved by the Food and Drug Administration between 2014 and 2019. They examined data spanning January 2016 through June 2021 at 619 U.S. Continue to STAT+ to read the full story…
Fierce Pharma
JULY 8, 2024
The traditional approvals follow initial accelerated approvals granted by the FDA in 2012 and the European Commission in 2014. It took many years, but Johnson & Johnson’s tuberculosis med Sirturo can finally claim full approvals in the U.S. and Europe following initial conditional nods. |
STAT
JANUARY 5, 2024
The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx , leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. Prasco, a U.S.
STAT
DECEMBER 13, 2024
When I left Syria in 2014, I had a dream of becoming a U.S.-trained trained physician. I quickly realized that the American dream is real and that hard work truly pays off.
The FDA Law Blog
MARCH 18, 2025
In the generic filers view, the regulatory review period should have started in January 2014 when the patent was reissued rather than in April 2004, when the IND was opened, because the reissued patent did not exist in April 2004. The plain text of 35 U.S.C.
STAT
SEPTEMBER 24, 2022
Amgen filed a lawsuit against the other companies in 2014 for allegedly infringing patents when they sought regulatory approval for their own medication. Continue to STAT+ to read the full story…
STAT
JANUARY 9, 2023
The researchers used clinician-level and practice acquisition data to study changes in the makeup of clinician workforces at private equity-acquired versus non-private equity-acquired dermatology, ophthalmology, and gastroenterology practices between 2014 and 2019.
STAT
NOVEMBER 4, 2022
Amgen filed a lawsuit against the other companies in 2014 for allegedly infringing patents when they sought regulatory approval for their own medication. At issue is a long-running battle between Amgen and a pair of rivals — Sanofi and Regeneron Pharmaceuticals — over the market for injectable cholesterol treatments.
STAT
NOVEMBER 8, 2023
But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments. The therapy, a simple procedure to reduce the blood pressure of millions of Americans , was once seen as a boon for cardiologists and device makers.
STAT
NOVEMBER 15, 2022
But the drug was bought by Leadiant Biosciences which, by 2014, began raising the price in several countries before withdrawing the medicine from the market entirely the following year. At issue is a medicine called CDCA that is used to treat people with a rare genetic metabolic disease known as cerebrotendinous xanthomatosis, or CTX.
STAT
NOVEMBER 4, 2022
When Tamiya Griffin was expecting her first child in 2014, she had what she thought was a straightforward plan: deliver at the hospital down the road, the same place her mother gave birth to her. But when Griffin, then a 22-year-old senior in college, went into labor a few weeks early, she had to undergo an emergency C-section.
Fierce Pharma
OCTOBER 18, 2023
Back in 2018, Irish authorities hit Shire with a €398 million charge tied to that company’s rejection of AbbVie’s takeover bid in 2014. . | Takeda will pay €130 million (about $137 million) to resolve a tax assessment from the Irish Revenue Commissioners, the company said Wednesday. Takeda ultimately purchased Shire for $62 billion in 2019.
Fierce Pharma
AUGUST 28, 2023
With seven posters and nine presentations on Farxiga over the weekend at the European Society of Cardiology (ESC) scientific sessions in Amsterdam, AstraZeneca made it clear that it has lots to say | As AstraZeneca's Farxiga has added four indications over the last five years—on top of its initial 2014 approval for Type 2 diabetes—its spillover (..)
IDStewardship
DECEMBER 13, 2024
Expert Consensus on Metrics to Assess the Impact of Patient-Level Antimicrobial Stewardship Interventions in Acute-Care Settings. Antimicrobial Stewardship Programs: Appropriate Measures and Metrics to Study their Impact. Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists.
STAT
SEPTEMBER 3, 2024
“That she took everything she knew about the pharmaceutical industry, having been part of it, and has really built a powerful advocacy for multiple myeloma patients, is remarkable,” said Tony Coles, who was CEO of Onyx Pharmaceuticals, a myeloma-focused biotech, from 2008 to 2014.
STAT
OCTOBER 2, 2023
Dispirited, she left in 2014 to work for consulting firm Avalere to build a device recall database. Critical information, like unique device identifiers that help hospitals keep track of implants in patients, was often missing. Patients and doctors alike often knew very little about the safety record of their devices.
STAT
JUNE 24, 2023
When Dana Lewis built her first artificial pancreas in 2014, she — and millions of other people with type 1 diabetes — didn’t have another option.
IDStewardship
DECEMBER 26, 2022
July 2014 – IDstewardship Facebook page created. July 2014 – IDstewardship Pinterest account created. April 2014 – @IDstewardship first post to Instagram. November 2018 – www.LearnAntibiotics.com created. November 2016 – @ASP_chat started on Twitter. March 2016 – www.IDstewardship.com created. 335,000 organic traffic visitors.
European Pharmaceutical Review
SEPTEMBER 12, 2023
The panelists referred to other documents that are useful for CCS development: the 2014 Pharmaceutical Healthcare Sciences Society (PHSS) Technical Monograph No 20 Bio-Contamination 2 as well as the Parenteral Drug Association (PDA) Technical Report 90: Contamination Control Strategy Development, 3 published in February 2023.
The Checkup by Singlecare
NOVEMBER 30, 2023
A 2014 review of studies summarizes this uncertainty, noting that some studies suggest it can help while others have been unable to confirm a link. Getting acupuncture. Dr. Swarup also notes that acupuncture has been studied for the treatment of allergies, though the evidence is inconclusive.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content